Pfizer Buys Company That Treats Turbo Cancer
Pfizer’s $43B cancer drug acquisition raises suspicion. CEO’s statements hint at broader, ominous implications beyond finance. NEW ARTICLE: Pfizer completes $43 Billion acquisition of Seagen on Dec.14, 2023 – becomes largest oncology company to treat most TURBO CANCERS caused by …